Two papers published in The New England Journal of Medicine highlight the potential of gene editing for treatment of sickle ...

Precedence Research introduces its Advanced Cell and Gene Therapy Intelligence Platform, turning complex data into actionable ...

Cell and gene therapies have a huge curative potential but come with a large price tag that can result in access barriers. At ...

Issued on behalf of Avaí Bio, Inc. VANCOUVER, BC, March 24, 2026 /PRNewswire/ -- USANewsGroup.com — The FDA has approved more than 40 cell and gene therapy products. The regenerative medicine market ...

The rapid evolution of advanced therapies like cell and gene therapies is reshaping the oncology landscape and challenging ...

In patients with advanced Claudin-18 isoform 2 (CLDN18.2) -positive gastric or gastroesophageal junction cancers, satricabtagene autoleucel (satri-cel) chimeric antigen receptor (CAR) T-cell therapy ...

Blood centers are scaling cell and gene therapies by leveraging decades of expertise in apheresis, logistics, and quality ...

Cell and gene therapies (CGT) continue to advance in the pharmaceutical industry. Despite continued investment in R&D, the ...

Oncology pharmacists can operationalize payer-mediated transitions such as biosimilar adoption, minimizing clinician burden while reducing waste and total cost of care. Earlier CAR T-cell therapy ...

The MarketWatch News Department was not involved in the creation of this content. Wellington, New Zealand and Kingston, Ontario--(Newsfile Corp. - April 7, 2026) - BioOra Limited ("BioOra"), a ...

The soft opening represents a significant milestone in RMTG's international expansion strategy, with plans to establish specialized infrastructure designed for the controlled manufacture, preservation ...

The MarketWatch News Department was not involved in the creation of this content. Cell Therapy Market Size to Surpass USD 17.15 Billion by 2032, Driven by Chronic Disease Treatment and CAR-T Therapy ...